Medicaid Denial and Recovery Benchmarks: What Hospitals Are Losing

Benchmarking data doesn't always confirm what revenue cycle leaders assume, but when it comes to Medicaid, this year's numbers align closely with what hospital billing teams have experienced for years: Medicaid claims are harder to collect than nearly any other payer category, and the gap has been widening rather than closing.

If you're looking for a broader overview of Medicaid's impact on hospital revenue cycle performance, start with Medicaid in Healthcare: A Hospital Revenue Cycle Guide. For background on why Medicaid claims are uniquely challenging, read Why Medicaid Claims Are Harder to Collect: What It Costs Hospitals. You can also compare Medicaid with commercial insurance in Medicaid vs. Commercial Payers: Key Billing Differences Hospitals Must Understand.

Medicaid Continues to Lead in Denial Rates

Kodiak Solutions, which aggregates revenue cycle data from more than 2,300 hospitals nationwide, reported in its March 2026 benchmarking analysis that Medicaid led all payer categories in both initial and final denial rates during 2025.

Across the industry, net revenue leakage from final denials and uncollected patient balances increased 25% year over year—from $38.6 billion in 2024 to more than $48.4 billion in 2025.

Although individual Medicaid claims generally reimburse less than commercial claims, the sheer volume of denied Medicaid claims makes them a significant contributor to overall hospital revenue leakage.

For hospitals serving large Medicaid populations, improving denial prevention often produces a greater financial impact than simply increasing collection efforts after claims have already been denied.

Initial Denial Rates Remain Significantly Higher

A separate survey conducted by Premier Inc. across more than 500 hospitals in 36 states found that Medicaid Managed Care Organizations (MCOs) denied 16.7% of claims on initial submission—the highest rate among all payer categories surveyed.

For internal benchmarking conversations, a few figures are worth keeping on hand:

• Initial denial rate, Medicaid managed care: 16.7 percent, versus 8.4 percent for traditional Medicare (Premier Inc., via TechTarget).

• Appeal overturn rate, Medicaid and Medicare combined: roughly 46 to 50 percent, versus 54.3 percent for private payers (Premier Inc., via HFMA).

• Industry-wide net revenue leakage from final denials and bad debt: $48.4 billion in 2025, up 25 percent from 2024 (Kodiak Solutions).

• Medicaid managed care prior authorization denials: only 11 percent were appealed, yet 46 percent of appealed cases were fully or partially overturned (HHS Office of Inspector General, via HFMA).

These findings reinforce why hospitals should treat Medicaid as a unique revenue cycle discipline rather than applying commercial payer workflows to every insurance type.

To better understand how Medicaid MCOs influence hospital billing, see What Are Medicaid Managed Care Organizations (MCOs), and How Do They Affect Hospital Billing?.

Appeals Recover Revenue—but Many Hospitals Never File Them

Denials are only part of the story.

Premier also found that Medicare and Medicaid combined achieved appeal overturn rates of approximately 46% to 50%, compared with 54.3% for private payers.

Those numbers suggest Medicaid denials are not only more common—they're also somewhat harder to overturn.

Yet another benchmark reveals an even larger opportunity.

According to the HHS Office of Inspector General, only 11% of Medicaid managed care prior authorization denials were appealed. Of those that were appealed, 46% were fully or partially overturned.

That means many hospitals may be leaving recoverable Medicaid revenue uncollected simply because appeals are never initiated.

Medicaid Benchmark Numbers Every Hospital Should Know

Revenue cycle leaders should compare their organization's performance against several important national benchmarks.

Initial denial rate (Medicaid Managed Care):

• 16.7%

• Compared with 8.4% for Traditional Medicare

Appeal overturn rate (Medicaid and Medicare combined):

• Approximately 46%–50%

• Compared with 54.3% for private payers

Industry-wide revenue leakage from final denials and bad debt (2025):

• $48.4 billion

• Up 25% from 2024

Prior authorization appeals (Medicaid Managed Care):

• Only 11% appealed

• 46% of appealed cases were fully or partially overturned

These benchmarks provide a useful starting point for evaluating Medicaid performance but should never replace organization-specific measurement.

Benchmark Your Medicaid Performance Separately

One of the biggest mistakes hospitals make is evaluating denial performance across all payers together.

A hospital with a 20% Medicaid denial rate and only a 30% appeal rate faces a very different operational challenge than one that aggressively appeals denials but performs below national recovery averages.

Benchmarking Medicaid separately helps identify where revenue is being lost:

• Eligibility and enrollment issues

• Managed care authorization requirements

• Filing deadline compliance

• Documentation deficiencies

• Appeal performance

• State-specific billing rules

Measuring these areas independently creates a much clearer picture of where operational improvements will generate the greatest financial return.

How Revecore Helps Hospitals Improve Medicaid Recovery

National benchmarks provide valuable context, but they don't explain why one hospital outperforms another.

Revecore helps hospitals build Medicaid recovery strategies using state-specific regulations, payer-specific requirements, and organization-specific performance data rather than relying solely on national averages.

Through Revecore's Medicaid Eligibility & Enrollment services, hospitals gain specialized expertise that helps improve eligibility accuracy, reduce avoidable denials, and strengthen Medicaid reimbursement from the beginning of the revenue cycle.

Rather than comparing performance against national averages alone, hospitals can identify where revenue is leaking within their own payer mix and implement targeted recovery strategies that improve financial performance over time.